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Supramolecular chemistry offers an exciting opportunity to assemble materials with mole-
cular precision. However, there remains an unmet need to turn molecular self-assembly into
functional materials and devices. Harnessing the inherent properties of both disordered
proteins and graphene oxide (GO), we report a disordered protein-GO co-assembling system
that through a diffusion-reaction process and disorder-to-order transitions generates hier-
archically organized materials that exhibit high stability and access to non-equilibrium on
demand. We use experimental approaches and molecular dynamics simulations to describe
the underlying molecular mechanism of formation and establish key rules for its design and
regulation. Through rapid prototyping techniques, we demonstrate the system’s capacity to
be controlled with spatio-temporal precision into well-deﬁned capillary-like ﬂuidic micro-
structures with a high level of biocompatibility and, importantly, the capacity to withstand
ﬂow. Our study presents an innovative approach to transform rational supramolecular design
into functional engineering with potential widespread use in microﬂuidic systems and organ-
on-a-chip platforms.
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There is an increasing interest to generate materials withbioinspired functions1, such as the capacity to grow2, self-replicate3, or controllably respond to speciﬁc stimuli4.
Biological materials acquire most of these functionalities as a
consequence of their ability to self-assemble various types of
building blocks at multiple length scales. Engineering materials in
this manner provides an opportunity to take advantage of the
individual building blocks while enabling emergent properties as
a result of their interactions5,6. Consequently, multicomponent
self-assembly represents an attractive route to develop more
complex materials7 with enhanced modularity and tuneability of
properties8,9, such as structural hierarchy10, adhesion11, electrical
conductivity12, or the capacity to grow13.
Proteins are the most functional building blocks of organisms14
and, as such, have been thoroughly explored to engineer intelli-
gent materials15–17. However, new discoveries are shaping our
understanding of how proteins function and providing new
insights for their utilization. For example, there is increasing
evidence that both ordered (i.e., β-sheet and α-helix) and dis-
ordered (i.e., random coil) regions of proteins play a role in their
functionality18 and growing acceptance that this functionality is
regulated by their interaction with other molecules19. Based on
these principles, proteins are emerging as dynamic building
blocks of multicomponent systems to engineer intelligent mate-
rials. We have recently reported on the possibility to exploit the
disordered nature of elastin-like recombinamers (ELRs) to
modulate their conformation and generate dynamic13 or hier-
archically mineralizing20 materials. ELRs, also known as the
recombinantly produced elastin-like polypeptides, are based on
the natural elastin motif Val-Pro-Gly-X-Gly (VPGXG), where X
could be any amino acid apart from proline21. These molecules
exhibit a reversible-phase transition with a change in temperature
and have been used to create biocompatible materials22.
Multicomponent self-assembly also offers a unique opportu-
nity to engineer complex hybrid systems. In particular, the con-
trolled incorporation of graphene as a building-block could lead
to the design of new biomaterials that beneﬁt from its distinctive
two-dimensional (2D) structure and outstanding electronic,
thermal, and mechanical properties23–25. Toward this goal, gra-
phene and its derivatives have been modiﬁed with biomacro-
molecules26, such as DNA27, proteins28, and biopolymers29 and
used in, for example, implants and scaffolds for cell culture and
regenerative medicine30,31. Furthermore, graphene oxide (GO) is
gaining signiﬁcant interest and being used instead of graphene
given its rich oxygen-containing functional groups (hydroxyl,
epoxy, carbonyl, and carboxyl), which facilitate designed inter-
actions with different molecules. However, both graphene and
GO exhibit key limitations such as dose-dependent toxicity and
issues associated with hierarchical organization and the ability to
generate uniform and stable structures24–26.
Material platforms that exploit the functionalities of both
proteins and GO and enable their multiscale organization offer
exciting possibilities for the engineering of advanced materials.
We report a hierarchical self-assembling system that takes
advantage of protein disorder-to-order transitions and supra-
molecular protein–GO interactions to enable both stable struc-
tures and access to non-equilibrium with spatial control to design
functional materials and devices. Experimental approaches and
molecular dynamics (MD) simulations were used to elucidate the
underlying molecular mechanism and develop rules for its use.
We show that the material can be combined with rapid-
prototyping techniques to assemble well-deﬁned tubular micro-
structures embedded with cells and into ﬂuidic devices. The study
introduces an innovative way to biofabricate by self-assembly
complex and functional devices such as microﬂuidic systems or
organ-on-a-chip devices.
Results
System rationale. Previous studies have demonstrated the pos-
sibility to co-assemble peptides with large macromolecules to
generate hierarchical membranes at a liquid–liquid interface10,13.
These systems rely on both molecular interactions, such as elec-
trostatic and hydrophobic forces between the two components as
well as their respective individual properties, such as molecular
weight, charge, and 3D conformation. In particular, by co-
assembling ELRs and peptide amphiphiles (PAs), we have pre-
viously reported on a diffusion–reaction mechanism that relies on
PA diffusion to give rise to a multilayer membrane that can access
non-equilibrium13. However, this material is fragile and can only
be assembled in and is stable under a narrow window of envir-
onmental conditions (pH, temperature, and salt concentration),
which limits its functionality and widespread use. Giving the need
for multicomponent approaches that can turn molecular design
into functional systems1, we envision the possibility to exploit the
inherent properties of GO to work synergistically with disordered
proteins to create materials with both emergent properties and
functionality. Speciﬁcally, we reasoned that, unlike the PAs, the
GO lamella conformation in aqueous environments32 would
provide a supramolecular framework with high surface area for
ELR interaction, reaching a level of integration far beyond that of
the ELR-PA system. Furthermore, the GO’s ﬂat-sheet organiza-
tion at air–liquid interfaces33 would facilitate the generation of a
diffusion–reaction process that takes advantage of the disordered
nature of ELRs to diffuse, conform, and integrate with GO,
generating a hierarchical process of assembly that can be
manipulated on demand. In this way, we hypothesized that the
co-assembly of GO and ELRs would lead to a robust supramo-
lecular system where both strong molecular interactions and
controllable access to non-equilibrium would lead to new mate-
rials with enhanced complexity and functionalities.
Materials rationale. We used GO sheets of two different average
lateral sizes, including larger GO (GO-L) measuring 10.5 ± 4.5 µm
and smaller GO (GO-S) of 2.3 ± 0.9 µm, both exhibiting a typical
hydrophobic surface and negatively charged carboxylic groups on
their periphery (Fig. 1b and Supplementary Fig. 1). We chose
ELRs as the protein component because of their modular and
disordered nature34 and the possibility to exhibit different
molecular conformations at different temperatures35. The
ELK1 sequence (Fig. 1a) is a 51.9 kDa molecule consisting of 24
repeats of a single block made of four hydrophobic pentapeptides
(VPGIG) and a positively charged (VPGKG) one. This relatively
simple molecular design offers an accessible transition tempera-
ture (Tt) of 30 °C (at 2% ELK1 in MilliQ water) with clearly
different ELR conformations above or below it, as well as medium
molecular weight to enable both cooperative interactions between
its charged and hydrophobic segments as well as with the anionic
edge and hydrophobic surface of the GO (Fig. 1c). ELRs with
similar molecular weight but different levels of charge and
hydrophobicity (Fig. 1a), as well as a single repeat of an individual
block of each of these three ELRs, were used as controls (Sup-
plementary Figs. 2–4).
Co-assembly. When an ELK1 solution at its Tt (30 °C) is
immersed in a larger volume of a GO solution, a multilayered
membrane of up to 50 µm in thickness develops at the interface
around the immersed drop maintaining both solutions separated
(Fig. 2a and Supplementary Movie 1). This membrane consists of
layers made from both GO sheets and ELK1 (Fig. 2b, confocal),
with GO sheets being present throughout the cross-section of the
membrane (Fig. 2b, SEM) and ELK1 gradually decreasing in
concentration from the inside (ELK1 side) to the outside (GO side)
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of the membrane (Fig. 2c and Supplementary Fig. 5). Multilayered
structures are known to emerge from diffusion–reaction mechan-
isms36. We have previously demonstrated that co-assembling PAs
with ELRs, it is possible to trigger a diffusion–reaction mechanism,
which generates multilayered membranes capable of exhibiting
dynamic properties13. Similarly, by touching any surface within the
ﬁrst few seconds of formation, the ELK1–GO membrane adheres,
spontaneously and reproducibly opens, and can be manipulated to
grow into tubular structures with spatiotemporal control (Fig. 2a,
d, and Supplementary Movie 2). However, in this case, the
underlying ELR-GO mechanism of interaction and supramolecular
assembly lead to the growth of a material with remarkably
enhanced properties.
Material structure, properties, and biofabrication of devices.
First, the ELK1–GO membrane is both dynamic and highly
stable, permitting controlled anisotropic growth of tubular geo-
metries that exhibit no apparent effects on their multilayered
structure when the temperature drops below (down to 4 °C) or
raises above (up to 70 °C) the Tt of ELK1. This enhanced stability
is also evidenced by the capability to co-assemble capillary-like
structures down to ~50 µm in internal diameter, deﬁned by the
size of the injecting tip. Moreover, the system also enables the
capacity to decrease the thickness of the wall down to ~10 µm,
achieved by removing the GO solution in order to stop the
assembly after ~2 min (Fig. 2e). While smaller diameters may be
possible by using smaller tips, wall-thicknesses below ~10 µm
were found to be too fragile to be manipulated. In addition, these
structures can be grown as tubular bridges between gaps by
simply touching, adhering, opening, and sealing to a surface soon
after co-assembly and continuing injecting ELK1 solution into the
GO solution until the next surface is touched (Fig. 2f and Sup-
plementary Movie 3). Moreover, the system works in salt-
containing solutions such as cell culture media, which enables co-
assembly and growth of capillary-like structures in the presence
of cells, resulting in structures comprising cells embedded within
and on the wall of the tube (Fig. 2g). Furthermore, given this
versatility and robustness, we demonstrated the possibility to use
rapid-prototyping techniques to guide the co-assembly process
using an extrusion-based 3-D printer to print the ELK1 solution
within a GO solution (Supplementary Movie 4), generating ﬂuidic
devices containing high-aspect ratio tubular structures of differ-
ent internal diameters and comprising curves (Fig. 2h, i and
Supplementary Movie 5), angles of different sizes (Fig. 2h, i), and
bifurcations (Fig. 2h, k and Supplementary Movie 6). The ﬂuidic
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Fig. 1 Molecular building blocks and rationale for co-assembly. a Table summarizes the key information of the three elastin-like recombinamers (ELRs)
used in the study comprising similar molecular weight but different levels of hydrophobicity (VPGIG) and positive charge (VPGKG). b Illustrations of the
molecular structure of a GO sheet and the supramolecular organization of ELK1 at its transition temperature (Tt) (30 °C) indicating both the charged (red
and green) and hydrophobic (brown) segments. c Schematic of the proposed mechanism of formation illustrating the molecular and supramolecular
conformation of the GO and ELK1 before and after co-assembly at the ELK1’s Tt as well as their interaction for membrane formation.
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Fig. 2 Co-assembly, structure, properties, and biofabrication of the ELK1–GO system. a Time-lapse images illustrate the dynamic properties of the
ELK1–GO membrane ﬁrst (a-Top forming a closed sac when a drop of ELK1 solution is immersed in a larger GO solution and second (a-Bottom) opening
upon touching an interface within the ﬁrst seconds of formation. b The membrane exhibits a multi-layered architecture of about 50 μm thick comprising
aligned GO sheets throughout (birefringence inset) interacting with ELK1 molecules (ﬂuorescence image, green: ELK1, red: GO), c which are observed to
decrease in concentration from the inside to the outside as evidenced by wavelength-dispersive spectroscopy (WDS). Only ELK1 comprises nitrogen in its
molecular structure. ±s.d. for n= 3. *p < 0.05. t test. d The system enables growing the membranes into longer tubes on demand by displacing an interface.
e The robustness of the system enables formation of capillaries down to about 50 μm in internal diameter with 10 μm thick walls, f bridging of surfaces
simply by touching two interfaces while injecting one solution into the other, and g co-assembling in salt solutions, opening the possibility to embed cells
(green identiﬁed by white arrows) within the membrane (outlined by dashed lines) as the tubes are formed. The images are taken after 24 h of culture and
correspond to a live (green)/dead (red) assay. Scanning electron micrographs of cells embedded within layers of GO (top) and a cross-section of the
ELK1–GO membrane comprising cells within different layers (bottom). h–l Images demonstrate the versatility of the co-assembly system by incorporating it
with 3D printing to fabricate well-deﬁned ﬂuidic devices consisting of high-aspect ratio tubular structures (h) of different internal diameters and comprising
curves, angles of different sizes, and bifurcations (h, i, l) capable of withstanding ﬂow within a few minutes of formation (j, k).
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devices were able to withstand aqueous ﬂows of up to 12.5 mL/
min for at least 24 h and within 60 min of formation (Supple-
mentary Movies 7 and 8). The highest ﬂows would generate 0.26
N/m2 shear stress, which is within the range of mean shear stress
values observed in common carotid arteries (0.7 N/m2)37. Alto-
gether, these capabilities suggest that the mechanism of formation
exhibits both strong ELK1–GO interactions at the molecular scale
and integrated organization at higher size scales (Supplementary
Fig. 6 (ELK1)).
Underlying molecular mechanism of assembly: ELK1–GO
molecular interactions. We ﬁrst tested the presence of both
electrostatic and hydrophobic forces by quantifying ELK–GO-
binding constants using ELRs with varying levels of charge and
hydrophobicity. Tubes formed on application of ELK1 and ELK3
but not ELK0, conﬁrming the need for electrostatic forces for its
assembly. Interestingly, the highest binding constant (Ka), cal-
culated by ﬂuorescence emission titration, was obtained with
ELK1 (1.3 × 106) compared to ELK0 (7.2 × 104) and ELK3 (3.2 ×
105) (Fig. 3a, Supplementary Fig. 6b, c). Using this method, we
also found that the optimum ELK1–GO concentration ratio to
maximize the interaction between them is 15–40 (Supplementary
Fig. 7). Therefore, keeping the ELK1 concentration at 2%, we
developed tubes using GO concentrations between 0.05% (cor-
responding to an ELK1–GO ratio of 40) and 0.15% (corre-
sponding to an ELK1–GO ratio of 15), and, as expected,
qualitatively found that the best-deﬁned and most robust tubes
were made within this range (Fig. 3b). To quantify and identify
the best ELK1–GO combination, we used an established nano-
tensile test38 on tubes made of 2% ELK1 and increasing con-
centrations of GO (0.05, 0.10, and 0.15%) (Supplementary
Section 14). As expected, the strength, the strain at break, and the
toughness modulus increased on tubes formed with increasing
concentrations of GO (Fig. 3c, Table). However, based on a
Weibull statistical distribution, the results revealed that the elastic
modulus was highest on tubes fabricated with 0.10% GO
(212.90–247.15 kPa) compared to 0.05% (128.78–147.37 kPa) and
0.15% (159.57–208.16 kPa). This result is also visible from the
stress–strain curves of the ELK1–GO (Fig. 3c, graph), where the
samples made with 0.1% GO show a steeper slope, meaning that
the material is stiffer.
In order to further investigate the role of electrostatic
interactions, we formed tubes with ELR and GO solutions at
varying pHs and again found that more robust membranes
formed when the charge difference between both components
was marginal (Fig. 3d, e). These results suggest that optimum co-
assembly does not solely depend on strong electrostatic forces but
rather on a synergistic effect from different factors that we
speculate to be electrostatic and hydrophobic forces, H-bonding,
and 3D conformation. To conﬁrm this premise, we ﬁrst
synthesized a single repeat of each individual ELR block. Using
CD and MD simulations, we veriﬁed that these shorter molecules
did not exhibit a Tt but have similar secondary structure with
large amounts of random coil in aqueous environments
(Supplementary Fig. 8). Upon mixing with GO, all three single
repeat peptides exhibited similar levels of interaction as evidenced
by calculation of the binding constant based on ﬂuorescence
emission titration (Supplementary Fig. 9). To further dissect the
nature of the initial ELK1–GO interactions, we performed MD
simulations at 30 °C and found that H-bonding between the
ELK1 and GO plays a role and that these interactions can come
from both the linear side chain of lysine and the backbone of the
peptide (Supplementary Section 18). However, in addition to
these ELK1–GO molecular interactions, we hypothesize that the
3D conformation of the full-length ELK1 protein and its ability to
cooperatively interact with the GO lamellae play a key role in the
formation of the system. To test this hypothesis, and taking
advantage of the ELR’s capacity to change its conformation at
different temperatures (Fig. 3f, graph, Supplementary Figs. 10
and 12), we assembled tubes using GO and ELK1 (2 wt%) at
either below (4 °C), above (45 °C), or the ELK1’s Tt (30 °C)
(Fig. 3f). While tubes formed at all temperatures, they were more
robust and exhibited better-deﬁned multilayers (Supplementary
Fig. 11e) and tubular geometry (Fig. 3f, images) at 30 °C,
suggesting stronger interactions at this temperature. This
enhanced interaction was also investigate by DLS, which revealed
the presence of larger ELK1–GO aggregates at 30 °C compared to
4 °C and 45 °C (Fig. 3g) and further conﬁrm that the 3D
conformation of ELK1 at the different temperatures plays a key
role in its interaction with the GO lamellae, which would in turn
affect the diffusion–reaction mechanism and consequently
determine the properties of the resulting ELK1–GO tubes (Fig. 3f,
images).
Underlying molecular mechanism of assembly: ELK1–GO
aggregates. To shed light on this enhanced ELK1–GO interaction
at 30 °C, we used SANS and found that, as expected, ELK1
exhibited an expanded conformation at 4 °C and a collapsed
aggregated conformation with a 74 nm radius of gyration of the
core region at 45 °C (Supplementary Fig. 10b). Furthermore, at
30 °C, the molecule acquired a conformation that combined both
an expanded structure and a collapsed aggregate core, consisting
of a 60 nm radius of gyration of the core region surrounded by a
larger 500 nm radius corona of expanded structures (Supple-
mentary Fig. 10b). These different conformations were conﬁrmed
by cryo-transmission electron microscopy (cryo-TEM) (Supple-
mentary Fig. 13). On the other hand, GO sheets are known to
stack and form lamellae32 in aqueous environments. We hypo-
thesized that the disordered nature of ELK1 would facilitate its
interaction with the supramolecular framework provided by the
GO lamella. To test this hypothesis, we used SANS to investigate
the size and shape of the ELK1–GO aggregates upon co-assembly
(Fig. 4a, b, and Supplementary Fig. 11a). We found that the
scattering proﬁle for the ELK1–GO aggregate formed at 30 °C is
better ﬁtted with a classical core–shell–bicelle–elliptical model39
with a core measuring 7 nm in length, a thick_rim of 22 nm, and
a thick_face of 16 nm (Supplementary Fig. 11d, e). According to
this model, the core is formed by GO and the shell by ELK1. This
core–shell conformation was conﬁrmed by confocal microscopy
(Fig. 4c). On the other hand, at 4 and 45 °C, the ELK1–GO
aggregates acquire longer cores and thinner shells (Supplemen-
tary Fig. 11d, e), which suggests that at these temperatures the GO
lamellae are less inﬁltrated by ELK1 molecules. In contrast, at
30 °C, the shorter core of the ELK1–GO aggregates indicates that
the GO lamellae are more inﬁltrated by and likely interacting
more with the ELK1 (Supplementary Fig. 11d, e).
Underlying molecular mechanism of assembly: disorder-to-
order transitions to enhance integration. It is well-known that
proteins rich in disordered regions change their conformation
upon binding to other molecules or surfaces40. We hypothesize
that the enhanced inﬁltration by ELK1 within the GO lamellae at
30 °C is associated to the disordered nature of the ELK1 and its
potential to acquire different secondary structures upon interac-
tion with other molecules. We ﬁrst used FT-IR amide III spectra
to conduct a quantitative analysis of the ELK1’s secondary
structure (Fig. 4d)20,41. At 30 °C and prior to co-assembly, ELK1
exhibits a high degree of random coil but also higher amounts of
α-helix and lower amounts of β-sheet compared to 4 and 45 °C
(Fig. 4d). Interestingly, upon binding with GO at 30 °C, ELK1
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maintains its α-helix and increases in β-sheet (Fig. 4d). These
results suggest that as ELK1 molecules diffuse through the GO
lamellae (Fig. 4a–c) at 30 °C, they bind to and interact with GO
maintaining their α-helix but increasing their levels of β-sheet
(Fig. 4d and Supplementary Figs. 10 and 11). It is known that
higher levels of β-sheet conformation generate denser aggre-
gates42 and that α-helix proteins lose entropy and increase the
system’s stability by aggregating their helices43. Therefore, it is
possible that these secondary structures enhance the stability of
the ELK1–GO complex and consequently lead to a better-deﬁned
diffusion barrier at the beginning of the co-assembly process,
which is known to have an effect on interfacial membrane
assembly44. To conﬁrm this, we attempted to form tubular
structures using the GO-S, which instead lead to a gel-like
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calculated by a Benesi–Hildebrand equation based on ﬂuorescence emission titration of a mixture of GO (2.5 × 10−3 wt%) in MilliQ water solution and
increasing concentrations of ELRs revealing higher Ka for ELK1–GO compared to ELK0–GO and ELK3–GO. b Table illustrating the role of building-block
concentration ratio on the formation of ELK1–GO tubes. c Nanotensile test results described with the Weibull distribution and reported in the table reveal
that the strength, the strain at break, and the toughness modulus increased on tubes formed with increasing concentrations of GO but the elastic modulus
was highest on tubes made with medium level (0.10%) GO compared to lower (0.05%) and higher (0.15%) amounts. d Table illustrating the role of pH
and ζ on the formation of the ELK1–GO tubes and their respective geometry. e Representative confocal microscopy qualitatively depicting the interface
between ELK1 (green) and GO (red) during tube formation with different levels of deﬁnition as characterized in d. f Red line of the graph shows the
turbidity changes of an ELK1 (2 wt%) solution in MilliQ water while inserted images depict the deﬁnition of tubes formed at speciﬁc temperatures.
g Dynamic light scattering (DLS) revealing the presence of larger ELK1–GO aggregates at 30 °C compared to 4 °C and 45 °C. Error bars represent ±s.d.
for n= 3. *p < 0.05. One-way ANOVA.
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structure, suggesting the formation of a loser and more permeable
diffusion barrier (Supplementary Fig. 1b).
Biological validation. The versatility and robustness of the
ELK1–GO system offers an exciting possibility to develop com-
plex and functional biohybrid devices with a high level of bio-
logical relevance by supramolecular processing. This potential
was assessed by suspending human umbilical vascular endothelial
cells (hUVECs) within the ELK1 solution prior to co-assembly
and growing the tubes described here. Fluorescence microscopy
revealed that cells were present both within the assembled
ELK1–GO membrane as well as inside the lumen of the corre-
sponding tubes right after co-assembly (Fig. 2g), which is likely a
result of cells being either trapped within or adhered to the
assembling membrane. Cells were observed to spread and grow
for at least 7 days both within the membrane and on the lumen of
the tubular structures, indicating that the material is able to
support cell survival and growth. To conﬁrm this ﬁnding, cell
adhesion and proliferation assays were conducted on both sides
of ELK1–GO wall of preformed tubes. Remarkably, cells were
found to adhere and proliferate at similar levels as those growing
on tissue culture plastic (TCP) (Fig. 5a, b), forming a conﬂuent
layer on both sides of the membrane (Fig. 5c). To further assess
the cell behavior on the tubular structures, VE–cadherin (CD144)
was labeled to observe the organization of the intercellular
junctions, which are critical for the formation of an intact
endothelial monolayer45. Confocal images revealed that hUVECs
were able to form an integral monolayer on both sides of the
ELK1–GO membrane (Fig. 5d).
This notable cell growth and spread on the co-assembled
membranes suggests that the hybrid material is cell friendly
in vitro. While ELR materials have been shown to support cell
growth46,47, GO is known to be cytotoxic to endothelial cells
in vitro at concentrations higher than 100 ng/mL as a result of
plasma membrane damage and oxidative stress48. It is important
to keep in mind that GO cytotoxicity depends on the inherent
properties of the speciﬁc GO used49. Therefore, we assessed the
cytotoxicity of the GO used in this study by conducting
experiments using hUVECs in media containing varying GO
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Fig. 4 Supramolecular assembly of the ELK1–GO system. a Small-angle neutron scattering (SANS) patterns demonstrating a resulting uniform
microstructure formed when co-assembling ELK1–GO. Between the middle-q region (ca 0.007–0.04 Å−1), the ELK1–GO structure (yellow triangle) exhibits
a characteristic scattering peak associated with pure ELK1 (green square) and GO (red circle) at 30 °C, conﬁrming the formation of a new order structure
different from the individual components. b The classical core–shell–bicelle–elliptical model that was ﬁtted to the ELK1–GO microstructure as measured by
SANS at 30 °C (green: ELK1, brown: GO). c Confocal microscopy (green: ELK1, red: GO) corroborating the interaction between the ELK1 and the GO
lamellae (inset depicts the top view of the ELK1–GO structure). d FT-IR calculation of secondary structure depicting the change and transition of
conformation of the ELK1 molecule before and after binding with GO. At 30 °C and before binding with GO, ELK1 exhibits higher α-helix than at 4 and
45 °C, which is maintained after binding with GO and is complemented with an increase in β-sheet.
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concentrations and found that our GO is toxic above 0.001%
(10 μg/mL) (Supplementary Fig. 14). However, when co-
assembling and growing ELK1–GO tubes in the presence of
hUVECs, we used GO concentrations that are up to 400× higher
than this cytotoxic limit, suggesting that the ELK1–GO complex
considerably decreases the cytotoxic level of the GO. This decrease
may be due to aggregation of GO sheets50 and the localization of
the ELK1 on the sharp edges of GO sheets51. To investigate
potential cytotoxicity as a result of membrane degradation, we
exposed tubes to cell culture media for different time points up to
15 days and used extracts from this media to culture hUVECs.
In this case, no cytotoxicity was observed for all time points
(Supplementary Fig. 15a) compared to hUVECs growing in fresh
culture media. Furthermore, by physically damaging ELK1–GO
tubes suspended in culture media using strong agitation and
exposing hUVECs to this suspension for 72 h, cells exhibited
higher viability compared to cells exposed to GO sheets at similar
levels of concentration (Supplementary Fig. 15b). To further
conﬁrm the biocompatibility of the material, we implanted
ELK1–GO tubes directly on an ex vivo preclinical chick
chorioallantoic membrane (CAM) model52 for 7 days and
assessed their cytotoxicity and angiogenesis. Using a Chalkley
count analysis, similar angiogenesis was observed on both tube-
containing samples and control samples (blank model) (Fig. 5f,
250
Day1 Day3 Day5 Day7
50
100
150
200
0
Ce
ll v
ia
bi
lity
 re
la
tiv
e 
to
 c
on
tro
l a
t d
ay
 1
Day5Day3Day1
a
b
c d
e
f
300 μm 
25 μm 
100 μm 
100 μm 
Outside
Inside
TCP control
ELK1
GO
ELK1-GO
50 μm 
Sc = Scaffold
10 μm 
Sc
Sc
Blank
0
5
10
15
M
ea
n 
Ch
al
kle
y 
sc
or
e
NS
ELK1-GO
Fig. 5 In vitro biocompatibility and bioactivity of the ELK1–GO membrane. a The applicability of the material was assessed by an MTS assay to test cell
viability and proliferation of hUVECS on both sides of the ELK1–GO membrane. The results revealed that cell viability and proliferation on ELK1–GO
materials are at least similar to those of cells growing on tissue culture plastic (TCP) for 7 days. Error bars represent ±s.d. for n= 3. *p < 0.05. Two-way
ANOVA. b Live (green)/dead (red) assay conﬁrmed the proliferation of hUVECs. c Scanning electron micrographs demonstrate the formation of an
integral endothelial layer on both sides of the ELK1–GO membrane. d VE–cadherin (CD144) was labeled to observe the organization of the intercellular
junctions and revealed that cells exhibited strong intercellular junction staining, also suggesting the formation of an integral endothelial layer on the
ELK1–GO membrane. e Histological sections of the ELK1–GO tube implants within a chick chorioallantoic membrane (CAM) model for 7 days highlighting
alpha smooth muscle actin (α-SMA, pink), and cell nuclei (blue). The results revealed endothelial cells forming capillary-like structures surrounding the
ELK1–GO tubes (yellow arrows). f Chalkley count analysis showing a slightly higher level of angiogenesis on tube-containing samples compared to control
(blank model) samples. ±s.d. for n= 3. *p < 0.05. One-way ANOVA. NS no signiﬁcance.
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Supplementary Fig. 16). Furthermore, immunohistochemistry
revealed the presence of capillary-like structures, which in many
cases appeared to develop and spread in the vicinity of the
ELK1–GO membrane (Fig. 5e). These results are in alignment
with previous studies demonstrating the angiogenic potential of
GO48. However, our approach permits this angiogenic potential
while enabling the use of much higher concentrations of GO.
Discussion
We have demonstrated the possibility to exploit multicomponent
self-assembly to hierarchically control the interactions between a
disordered protein and GO and grow hybrid materials and
devices with a spectrum of new functionalities. The system takes
advantage of the inherent properties of both GO and ELRs to
trigger a diffusion–reaction process that enables disorder-to-order
transitions to facilitate GO–disordered protein interactions,
supramolecular integration, and hierarchical assembly. Based on
both experimental and simulation evidences, we have described
the key steps of the underlying molecular mechanism and
established rules to grow the material and easily assemble func-
tional devices. The system exhibits a series of properties that
emerge from the synergistic interaction between the two com-
ponents, including remarkable stability, access to non-
equilibrium for substantial periods of time, robustness of
assembly, biocompatibility, and bioactivity. We have shown how
these properties enable its integration with rapid-prototyping
techniques to biofabricate functional microﬂuidic devices by
directed self-assembly, opening new opportunities for engineering
more complex and biologically relevant tissue engineered scaf-
folds, microﬂuidic systems, or organ-on-a-chip devices. Further-
more, our study addresses a major challenge in materials science
by demonstrating the possibility to bridge the gap between
supramolecular design and functional and robust biomedical
engineering.
Method
Chemicals. 4-methylbenzhydrylamine (MBHA) rink amide resin and ﬂuor-
enylmethyloxycarbonyl (Fmoc)-protected amino acids were purchased from Merck
Millipore. 1-hydroxybenzotriazole (HOBt) hydrate was purchased from Cambridge
Bioscience. N,N′-diisopropylcarbodiimide (DIC), dimethylformamide (DMF),
dichloromethane (DCM), piperidine, triﬂuoroacetic acid (TFA), triisopropylsilane
(TIS), diethyl ether, acetonitrile (ACN), acetic anhydride and Kaiser Test Kit were
purchased from Sigma-Aldrich and used without further puriﬁcation. Rhodamine
B (≥95%, HPLC grade) and paraformaldehyde (95%) were obtained from Sigma-
Aldrich. Two kinds of GO (GO-L with product number-777676; GO-S with pro-
duct number-763705) were obtained from Sigma-Aldrich. The GOs’ size dis-
tribution can be found in Supplementary Fig. 1. Alexa Fluor™ 488 NHS Ester
(Succinimidyl Ester) was obtained from Thermo Fisher Scientiﬁc.
Synthesis and characterization of ELRs. ELK0, ELK1, and ELK3 molecules were
provided by TP Nanobiotechnology (Valladolid, Spain). Figure 1a shows the
sequences, molecular weights, and inverse-phase Tt of the ELRs. ELRs were syn-
thesized by Escherichia coli recombinant expression system. The sequence and
molecular weights of the polymers were veriﬁed using amino acid analysis. Sodium
dodecyl sulfate–polyacrylamide gel electrophoresis and matrix-assisted laser des-
orption/ionization-time-of-ﬂight SIMS were used to carry out the ELRs
characterization.
Peptide synthesis and puriﬁcation. Peptides representative of the single repeat of
an individual ELR block were synthesized in a microwave-assisted automated
peptide synthesizer (Liberty Blue, CEM) using the standard solid phase peptide
synthesis method and Fmoc-protection chemistry. Because the individual blocks
are linked together in the ELR molecule through peptide (amide) bonds, synthe-
sized peptides were amidated at the C-terminus and acetylated at N-terminus to
resemble the continuation of the amide backbone character and not introducing
any additional charges. MBHA rink amide resin was used as the solid support.
Amino acid couplings were performed with a mixture of Fmoc-amino acid/HOBt/
DIC at a molar ratio of 4:4:4, relative to the resin. Fmoc deprotections were
performed with 20% (v/v) piperidine in DMF for 10 min twice. Once all coupling
and deprotection reactions were completed, the N-terminal of the peptides were
manually capped with 20% acetic anhydride in DMF for 20 min twice. Acetylation
reaction was monitored with Kaiser test for free amines. Peptides were then cleaved
from the resin with a mixture of TFA/TIS/H2O at a volume ratio of 95:2.5:2.5 for
2 h with simultaneous removal of side-chain protecting groups. The cleavage
solution was then collected and the excess of TFA removed by rotary evaporation.
Cold diethyl ether was added to precipitate the peptide product, which was then
collected, washed again with cold diethyl ether and dried under vacuum overnight.
Mass of the crude product was analyzed via electrospray ionization mass spec-
trometry (ESI–MS, Agilent).
Puriﬁcation of the peptides was performed in an AutoPuriﬁcation System
(Waters) using a preparative reverse-phase C18 column (XBridge, 130 Å, 5 µM,
30 × 150mm, Waters) and H2O/ACN (0.1% TFA) as mobile phase. Fractions
containing the peptides were automatically collected when their exact mass was
detected in the SQ Mass Detector (Waters). The collected peptide fractions were
lyophilized and stored at −20 °C until further use.
Mass conﬁrmation for all peptides was performed via ESI–MS and their purity
analyzed in an Alliance HPLC system (Waters) equipped with an analytical
reverse-phase C18 column (XBridge, 130 Å, 3.5 µM, 4.6 × 150 mm, Waters) and
monitored at 220 nm.
Sample preparation (ELRs–GO system). Aqueous suspension of GO (0.1 wt%,
100 μL) was added to a well of 96-well TCP and aqueous solution of the ELRs (2 wt
%, 18 μL) was slowly injected into the suspension of GO. The tip of the pipette was
allowed to make contact with the bottom of the well before releasing the ELRs
solution vertically at a constant speed. All samples were prepared in MilliQ water.
Temperature-controlled spectrophotometry. The thermo-responsive behavior of
ELK1 at certain concentration (2 wt%) and pH 8 was determined on a
temperature-controlled UV–visible spectrophotometer (Agilent Technologies).
ELR samples (2 wt%) were prepared in MilliQ water and the pH of the solutions
was adjusted with HCl (0.5 M) and NH4OH (1.0 M) prior to heating at 1 °C/min
ramping rate. Absorbance of the samples was obtained at λ= 350 nm.
Zeta potential (ζ). In order to optimize the formation of the ELK1–GO system,
the zeta potential of both ELK1 and GO was measured on Zetasizer (Nano-ZS ZEN
3600, Malvern Instruments, UK) at 30 °C under various pH conditions. The
concentration of ELK1 and GO used for the measurements is 0.025 and 0.00125 wt
%, respectively. The pH values of the two component solutions were adjusted using
0.5 M HCl (at most 3 μL into 1 mL ELK1 or GO solution) and 1.0 M NH4OH (at
most 2 μL into 1 mL ELK1 or GO solution) and the samples were equilibrated for
10 min at the set temperature prior to the measurement of zeta potential.
Dynamic light scattering (DLS). DLS was performed to measure changes in the
particle size of ELK1–GO aggregates at 4 °C (below ELK1’s Tt), 30 °C (at the Tt),
and 45 °C (above the Tt). The ELK1 and GO were dissolved in MilliQ water at the
concentrations of 0.2 and 0.01% separately. The two solutions were mixed in a 1:1
ratio and the particle sizes were measured using Zetasizer (Nano-ZS ZEN 3600,
Malvern Instruments, UK). Samples were equilibrated for 10 min at the desired
temperature before measurements.
Fluorescence emission. Fluorescence emission was measured on LS 55 spectro-
ﬂuorometer (Perkin Elmer). The aqueous solution of GO (2.5 × 10−3 wt%, 1.5 mL)
and the solution of various concentrations of ELRs (1.5 mL) were mixed in a
10 mm path length cuvette at 30 °C. The excitation and emission slits were set at
10 nm. The GO was excited at 255 nm and the emission spectra were collected
between 300 and 700 nm (200 nm/min). The ﬂuorescence emission intensity was
recorded at 518 nm. The data were ﬁtted into the Benesi–Hildebrand equation (1)
in order to determine the association/binding constant (Ka) between GO and ELRs.
1=ΔI ¼ 1=ΔImax þ ð1=Ka½CÞð1=ΔImaxÞ ð1Þ
where [C] is the concentration of ELRs, ΔI= I− Imin and ΔImax= Imax− Imin,
where Imin, I, and Imax are the emission intensities of GO considered in the absence
of ELRs, at an intermediate ELRs concentration and a concentration of complete
saturation, respectively. From the plot of (Imax− Imin)/(I− Imin) against [C]−1 for
GO, the value of Ka was determined from the slope.
Circular dichroism (CD). VT-CD measurements were carried out on Chirascan™
CD Spectrometer (Applied Photophysic Limited, UK) from 10 to 40 °C. The
solutions of ELK1 (0.01 wt%) were prepared in MilliQ water and incubated at each
temperature for 10 min before measurements. A quartz cuvette with 0.1 cm path
length was used for the measurements and CD spectra were obtained by signal
integrating 10 scans, from 190 to 260 nm at speed of 50 nm/min. Data were pro-
cessed by a simple moving average and smoothing method.
Fourier transform infrared spectroscopy (FT-IR). FT-IR analysis was conducted
on FT-IR spectrometer GX (PerkinElmer®, Waltham, MA, USA). A solution of
ELK1 (2 wt%) in a mixture of D2O and H2O (75/25 v/v) and the preformed
ELK1–GO membranes prepared in the same solution were properly secured over
the IR window before scanning. All samples were incubated and formed at 4, 30,
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and 45 °C for 10 min before measurements. The program was set to take the
average of 160 scans at a resolution of 2 cm−1 after subtracting the background and
spectra were obtained at wavenumber 4000–600 cm−1 with respect to the absor-
bance for all samples. In order to quantitatively determine the maximum
absorption intensity corresponding to various secondary structures of the ELRs (α-
helix, β-sheets, β-turns, and random coils) amide III region (1350–1200 cm−1) was
analyzed using second derivative of a Guassian and Lorentian curve ﬁttings. The
second derivative ﬁngerprints for the secondary structures of the ELRs are as
follows: 1220–1250 cm−1 for β-sheets, 1250–1270 cm−1 for random coils,
1270–1295 cm−1 for β-turns, 1295–1330 cm−1 for α-helix, as previously suggested
by Cai et al41.
Scanning electron microscopy (SEM) and wavelength-dispersive spectro-
scopy (WDS). The microstructures of ELRs–GO and ELK1–GO membranes
cocultured with HUVECs were examined by SEM. ELK1–GO membranes with
HUVECs were ﬁxed with 4% paraformaldehyde in MilliQ water for 20 min before
dehydration while ELRs-GO membranes were dehydrated directly using increasing
concentrations of ethanol (20, 50, 70, 90, 96, and 100%). All samples were subjected
to critical point drying (K850, Quorum Technologies, UK) prior imaging. The SEM
micrographs were captured on Inspect F50 (FEI Comp, the Netherlands) after
sputter-coating with gold (10 nm thick). WDS elemental analyses were performed
to study the molecular composition of both the inner and outer surfaces of the
ELK1–GO membranes. Quantitative Nitrogen elements (nitrogen exists in ELRs
not in GO.) were also analyzed using the Inspect F50 (FEI Comp, the Netherlands).
All samples consisting only ELRs or GO were prepared for SEM imaging without a
prior cross-linking process.
Cryo-transmission electron microscopy (Cryo-TEM). The ELK1 solutions were
prepared at 2 wt% in MilliQ water. Grids were vitriﬁed using the Vitrobot MK IV.
The Vitrobot chamber was equilibrated to the desired temperature (4, 30, or 45 °C),
at 95% relative humidity. Quantifoil R 1.2/1.3 grids were glow discharged in air
using the Quorum GloQube® for 60 s, 40 mA. Grid tweezers, grid and pipette tips
were preheated to protein aggregate temperature before using. Totally, 3 μL of
sample was applied to the grid, blotted for 5 or 6 s with a blot force of 6. Cryo-TEM
imaging was performed on a Titan Krios microscope (Thermo Fisher Scientiﬁc,
US) operating at 300 kV, using a Falcon III direct electron detector.
Confocal microscopy. The interaction and localization of ELK1 and GO was
probed using laser scanning confocal and multiphoton microscopy (TCS SP2, Leica
Microsystems, Germany). ELK1 (2 wt%) was dissolved in an aqueous solution of
Alexa Fluor™ 488 NHS Ester (10−6 wt%) and GO were diluted to 0.1 wt% with an
aqueous solution of Rhodamine (10−6 wt%). All solutions were incubated for
20 min at 30 °C and protected from light. The tubes were fabricated with 50 μL
GO-Rhodamine solution and 10 μL ELK1-Alexa Fluor solution in a 96-well Petri
dish as previously described. Images were acquired at laser wavelengths of 488 and
543 nm which correspond to the excitation wavelength of Alexa Fluor and rho-
damine, respectively. Images were further processed using ImageJ.
Small-angle neutron scattering (SANS). The GO suspension and ELK1 were
dissolved in H2O/D2O (25%/75%) respectively with 0.1 and 2%. SANS measure-
ments were performed on the ﬁxed-geometry, time-of-ﬂight LARMOR dif-
fractometer (ISIS Neutron and Muon Source, Oxfordshire, UK). A white beam of
radiation with neutron wavelengths spanning 2.2 to 10 Å was enabled access to Q
[Q= 4πsin (θ/2)/λ] range of 0.004–0.4 Å−1 with a ﬁxed-sample detector distance of
4.1 m. Solutions (0.4 mL) of individual components were contained in 1 mm path
length UV spectrophotometer grade quartz cuvettes (Hellman) while the composite
materials were prepared by mixing equal volume (0.2 mL) of both components in a
demountable 1 mm path length cuvettes. The cuvettes were mounted in aluminum
holders on top of an enclosed, computer-controlled sample chamber at 30 °C. For
the variable temperatures (VTs) experiment (especially those involving ELK1 at 4,
30, and 45 °C), a thermostatted circulating water bath was ﬁtted with the sample
chamber. Time taken for each measurement was approximately 30 min. All scat-
tering data were normalized for the sample transmission, the backgrounds was
corrected using a quartz cell ﬁlled with D2O or H2O/D2O (25%/75%) and the
linearity and efﬁciency of the detector response was corrected using the
instrument-speciﬁc software.
In the present SANS experiments, we consider that the scattering length density
(SLD) of the H2O/ D2O (25%/75%) is a volume fraction weighted average of the
SLDs of the individual components. Given the SLDs for H2O and D2O are −5.6 ×
10−7 Å−1 and 6.3 × 10−6 Å−1, we determined the SLD of the H2O/D2O (25%/75%)
is 4.653 × 10−6 Å−1. The neutron scattering length densities for the GO, H2O/D2O,
and ELK1 are summarized in Supplementary Fig. 11c.
Cell culture. Human umbilical vein endothelial cells (hUVECs) (Lonza, Isolated in
EGM™-2 Media, C2519A) were cultured in EGM™-2 Media (Lonza, CC-3156 and
CC-4176). The medium was changed every 3 days until the cells reached 80%
conﬂuency. hUVECs between passage 2 and 4 were used for experiments. The
tubes were ﬁrst washed three times with phosphate-buffered saline (PBS) 8 h after
assembly and sterilized with UV for 45 min. Then each tube was placed in a well of
48-well cell culture plate with inner or outer side facing up. The EGM™-2 Media
(500 μL) containing 50,000 cells was added to each well containing ELK1–GO
membranes, coated with ELRs solution (18 μL, 2 wt%), GO (20 μL, 0.1 wt% GO) or
on TCP (positive control). The coated wells were incubated for 8 h prior to cell
seeding. The cells were incubated at 37 °C and 5% CO2 for different time points for
all tests (protocol shown below).
Cell viability and proliferation assay and cytotoxicity assay. The effect of
ELK1–GO membranes on hUVECs viability and proliferation using the CellTiter
96® Aqueous One Solution Cell Proliferation Assay (Promega, Southampton, UK).
Cells were seeded at a concentration of 50,000 cells/well in 48-well plates. After
incubation for 24 h, 1 d, 3 d, 5 d, 7 d, cell culture medium was aspirated and 500 μL
of EGM™-2 Media containing 10% MTS reagent was added to each well. Plates
were subsequently incubated for 3 h at 37 °C and the absorbance was read at
490 nm using Inﬁnite F50 plate reader (Tecan, Switzerland). Five replicates of each
condition were performed with each assay repeated in triplicate. The cell viability
was determined as a percentage of control cell viability and proliferation.
A LIVE-DEAD® Cytotoxicity Assay Kit (Invitrogen, USA) was used to measure
the viability of hUVECs seeded on the ELK1–GO membranes. Five replicates of
each condition were performed with each assay repeated in triplicate. A stock
solution containing calcein AM (1 μM) and ethidium homodimer (2 μM) in PBS
was prepared according to the assay instructions, and 200 μL of stock solution was
added to each well. Fluorescence images were captured on laser scanning confocal
and multiphoton microscopy (TCS SP2, Leica Microsystems, Germany). Viable
cells were stained green with calcein AM (ex 495 nm, em 530 ± 12.5 nm), while
dead cells red with ethidium homodimer (ex 528 nm, em 645 ± 20 nm).
GFP-hUVECs (Fisher scientiﬁc, Angio Proteomie GFP-hUVECs, NC0601093,
USA) were used to assess the cytotoxicity of GO by culturing >95% conﬂuent GFP-
hUVECs in media containing varying GO concentrations (0, 0.001, 0.0025, 0.005,
0.01, 0.25, 0.05, and 0.1%) and cultured for 48 h. Fluorescent images were taken at
1, 8, 24, and 48 h to assess the cytotoxicity by morphology and conﬂuency analysis.
GFP-hUVECs were also used to assess the potential cytotoxicity of ELK1–GO
degradation products (extracts). We exposed 1 tube fabricated by 100 µL 0.1% GO
and 18 µL 2% ELK1 to 1 mL cell culture media for different periods of time s (1, 3,
6, 9, 12, and 15 days) and used the extracts from this media to culture >95%
conﬂuent GFP-hUVECs for 7 days. Fluorescent images were taken at day 1 and day
7 to assess the cytotoxicity by morphology and conﬂuency. To further assess the
potential physical degradation of ELK1–GO, physically damaged ELK1–GO tubes
using strong agitation were suspended in culture media and exposing >95%
conﬂuent GFP-hUVECs to this suspension for 72 h. Fluorescent images were taken
to assess the cytotoxicity.
Immunoﬂuorescence staining. hUVECs on the ELK1–GO membrane were ﬁxed
with 4% paraformaldehyde (Sigma, USA), washed and permeabilized with 0.5%
Triton X-100 (Sigma, USA), and then rinsed 3 times with PBS. Nonspeciﬁc binding
sites were blocked by PBS containing 1% bovine serum albumin. The CD144
marker was labeled by incubating the cells at room temperature for 1 h with anti-
rabbit monoclonal VE–cadherin primary antibody (1:400, ab33168, Abcam, UK).
Cells were then washed and incubated for 50 min at room temperature in Alexa
488 conjugated anti-Rabbit IgG as Secondary Antibody (1:1000, R37116, Invitro-
gen, USA). The stained ELK1–GO membranes were then transferred to slides and
visualized on a laser scanning confocal and multiphoton microscopy (TCS SP2,
Leica Microsystems, Germany) utilizing ×10 and ×40 objectives.
Chick chorioallantoic membrane (CAM) assay. Fertilized chick eggs (Gallus
domesticus) were kept in a hatchmaster (Brinsea, UK) incubated at 37.5 °C and
humidiﬁed with rotation. Twelve (six per group: blank control group and
ELK1–GO group) day 1 fertilized eggs were maintained within the hatchmaster.
After candling the egg to determine if the egg is fertilized a window was created at
day 7 under sterile conditions. A window was created by scoring with a scalpel and
an approximately 6 mm square opening created in the outer shell of the egg. The
membrane was removed from the underlying CAM vascular membrane. ELK1–GO
tube samples were inserted into the window and onto the chorioallantoic mem-
brane. Eggs were transferred to a Hatchmaster incubator and incubated for a
duration of 8 days at 37.5 °C 60% humidity without rotation. All procedures were
performed in accordance with ethical approval and in accordance with the Animal
(Scientiﬁc Procedures) Act 1986, UK (Project License number P3E01C456). After
8 days of the CAM culture the implanted samples were harvested.
Immunohistology staining. Slides were ﬁrst deparafﬁnized by washing in two
changes of xylene (Sigma, UK) and graded ethanol baths (absolute ethanol, 90%,
70%). Antigen retrieval was performed to unmask the antigenic epitope of the
tissue sample by boiling the deparafﬁnized sections in citrate buffer (Vector
laboratories, UK) at pH 6.0. Endogenous peroxidase activity was blocked by
incubating sections in 3% H2O2 solution (Sigma, UK) in PBS at room temperature
for 10 min followed by two rinses in PBS. To reduce background staining and any
other immunostaining application, the samples were incubated with normal goat
serum (5% in PBS, Vector laboratories, UK) to block nonspeciﬁc binding sites in a
humidiﬁed chamber at room temperature for 1 h before staining. After draining the
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blocking buffer, 100 µL of diluted primary anti-α-SMA antibody (1:500, ab5694,
Abcam, UK) was added to the sections on the slides and incubated in a humidiﬁed
chamber at room temperature for 1 h, after which the slides were washed twice in
PBS. Then, 100 µL of ready-to-use biotinylated anti-mouse/rabbit IgG secondary
antibody (Ready-to-use, PK-7200, Vector laboratories, UK) was applied to the
sections on the slides and incubated in a humidiﬁed chamber at room temperature
for 30 min with the slides washed in PBS after that. Ampliﬁcation of antigen was
achieved using an Elite® ABC-HRP Kit (PK-7200, Vector Laboratories, UK) and
positive staining was visualized by incubating in a peroxidase substrate solution
using a DAB Peroxidase (HRP) Substrate Kit (PK-7200, Vector laboratories, UK).
Analysis of goldner’s trichrome staining by Chalkley count. The Chalkley
point-overlap morphometric technique is a relative area estimate method to
measure the abundance of microvessels in an immunohistochemical sample. A
“Chalkley point array graticule” was used to ﬁt onto the eyepiece of a microscope.
This graticule consists of a grid that contain 25 random dots which can be rotated
360°. An observer can overlay these dots over structures that have stained positively
with goldner’s trichrome. The rotational position with the most dots that land on
positively stained structures is described as the “Chalkley count” and samples have
higher counts are considered to contain a greater abundance of blood vessels. A
blank histological slide sample and three ELK1–GO histological slide samples were
scoring by this technique.
Co-assembly of ELK1–GO–hUVECs. EGM™-2 Media containing hUVECs
(105 cells/ml) was used to dissolved the ELK1 (2 wt%). The ELK1–hUVECs media
(10 μL) was added into GO (50 μL, 0.4 wt%) solution to make a tube as previously
described. All these co-assembled ELK1–GO–hUVECs tubes were incubated at
37 °C, 5% CO2 for 24 h, 1 d, 3 d, 5 d prior to LIVE-DEAD® cytotoxicity Assay and
SEM procedures as described previously.
3-D printing of ELK1-GO materials. A PAM2 system (Centro Piaggio, Pisa
University, Italy) was applied for the 3-D printing of ELK1–GO materials. Blue
food dye (5 μL) was added into aqueous solution of ELK1 (2 mL, 2 wt%) to make
the printing procedure visible. For fabricating the different shapes of structures and
the 60 μm diameter small tube, a 65 μm diameter glass tube tip was used as nozzle
to release the solution of the ELK1 and the dye under 4 kPa pressure at a range of
speed between 10 and 18 mm/s. The printing nozzle is merged in a container with
0.1% GO MilliQ water solution. All the 3-D pathway was controlled by the Repetier
software. A peristaltic pump was used to perfuse 1 v/v green food dye in MilliQ
water. For the vertical tube, the perfusion speed is from 4.7 to 8.3 mL/min. For
other structures, the perfusion speed was 2 mL/min.
Statistical analysis. GraphPad Prism 5 was applied for data analysis. Studentʼs
t-test statistical analysis was applied for all the measured data.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The data that support the ﬁndings of this study are available from the authors on
reasonable request, see author contributions for speciﬁc data sets.
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